Materials and Methods
Tissue Preparation and Treatment. Uterine arteries were harvested from nonpregnant sheep regardless of stages of the estrous cycle and near-term pregnant (140 days' gestation) ewes maintained at sea level (~300m, arterial PaO 2 102 mmHg) or exposed to high-altitude (3801m, arterial PaO 2 60 mmHg) hypoxia for 110 days. 1 Animals were anesthetized with thiamylal (10 mg/kg, i.v.) followed by inhalation of 1.5% to 2.0% halothane. An incision was made in the abdomen and the uterus exposed. The resistance-sized uterine arteries (150 m in diameter) were isolated and removed without stretching and placed into a modified Krebs solution. To investigate the direct effect of hypoxia, some arteries obtained from normoxic control nonpregnant and pregnant animals were treated in a humidified incubator with either 21.0% or 10.5% O 2 for 48 hours, as described previously. 1 All procedures and protocols were approved by the Institutional Animal Care and Use Committee and followed the guidelines by the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Reporter Gene Assay. Genomic DNA isolated in uterine arteries from control nonpregnant animals was used as a PCR template. Using primers designed based on the bovine ER gene promoter sequence (Gene ID: 407238), a 2035 bp ovine genomic fragment spanning -2000 bp to +35 bp relative to the transcription start site was first cloned into pCR4-TOPO vector and subsequently cloned in Xho I-Hind III orientation in pGL3 basic vector (Promega) to drive the transcription of the luciferase reporter gene. Site-specific deletion mutations were constructed at three putative transcription factor binding sites, USF -15 , Sp1 -520 , and PRA/B -563 , as described previously. 2 All promoter constructs sequences were confirmed with DNA sequencing analyses.
Smooth muscle cells isolated from uterine arteries of normoxic control nonpregnant sheep were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C in 95% air/5% CO2. Cells were grown and sub-cultured in 24-well plates with experiments performed at 70-80% confluent. Cells were transiently co-transfected with 1 μg of promoter/reporter vector along with 0.1 μg of internal control pRL-SV40 vector using endotoxin free plasmid DNA plus X-tremeGENE HP DNA Transfection Reagent (Roche) following manufacturer's instructions. After 48 hours, firefly and Renilla reniformis luciferase activities in cell extracts were measured in a luminometer using a dual-luciferase reporter assay system (Promega), as described previously. 2, 3 The activities of the wild-type or site specific deletion constructs were then calculated by normalizing the firefly luciferase activities to R. reniformis luciferase activity, and expressed as relative to wild-type reporter activity (% WT).
Quantitative Methylation-Specific PCR. Genomic DNA was isolated from uterine arteries of all four group animals using a GenElute Mammalian Genomic DNA Mini-Prep kit (Sigma), denatured with 2 N NaOH at 42°C for 15 minutes, treated with sodium bisulfite at 55°C for 16 hours, and purified by EZ DNA Methylation-Gold Kit TM (Zymo Research), as previously described. 3, 4 Bisulfite-treated DNA was used as a template for real-time fluorogenic methylationspecific PCR (MSP) using specific primers designed to amplify the regions of interest with unmethylated CpG dinucleotides or methylated CpG dinucleotides (C m G), respectively (Table  S1 , available in the online data supplement). GAPDH was used as an internal reference gene. Real-time MSP was performed using the iQ SYBR Green Supermix with iCycler real-time PCR system (Bio-Rad). Data are presented as the percent of methylation at the region of interest (methylated CpG/methylated CpG + unmethylated CpG x100), as described before. 3, 4 Electrophoretic Mobility Shift Assay (EMSA). Nuclear extracts were collected in uterine arteries from control nonpregnant animals using NXTRACT CelLytic Nuclear Extraction Kit (Sigma, St. Louis, MO). The oligonucleotide probes with CpG and C m G in the three putative transcription factor binding sites, USF -15 , Sp1 -520 , and PRA/B -563 at ovine ER promoter region were labeled and subjected to gel shift assays using the Biotin 3′ end labeling kit and Light-Shift Chemiluminescent EMSA Kit (Pierce Biotechnology, Rockford, IL), as previously described. 3, 4 Briefly, single stranded oligos were incubated with Terminal Deoxynucleotidyl Transferase (TdT) and Biotin-11-dUTP in binding mixture for 30 minutes at 37ºC. The TdT adds a biotin labeled dUTP to the 3'-end of the oligonucleotides. The oligos were extracted using chloroform and isoamyl alcohol to remove the enzyme and unincorporated biotin-11-dUTP. Dot blots were performed to ensure the oligos were labeled equally. Combining sense and antisense oligos and exposing to 95ºC for 2 minutes was done to anneal complementary oligos. The labeled oligonucleotides were then incubated with or without nuclear extracts in the binding buffer (from Light-Shift kit). Binding reactions were performed in 20 μl containing 50 fmol oligonucleotide probes, 1× binding buffer, 1 μg of poly (dIdC), and 10 μg of nuclear extracts. For competitions studies, 200-fold molar excess of non-labeled oligonucleotides were added to binding reactions. For super-shift assays, 2 µl of affinity purified Sp1 antibody (Active Motif) or USF1 or USF2 antibodies (Santa Cruz) were added to the binding reaction. The samples were then run on a native 5% polyacrylamide gel. The contents of the gel were then transferred to a nylon membrane (Pierce Biotechnology, Rockford, IL) and crosslinked to the membrane using a UV crosslinker (125 mJoules/cm 2 ). Membranes were blocked and then visualized using the reagents provided in the LightShift kit.
Chromatin Immunoprecipitation (ChIP). Chromatin extracts were prepared from uterine arteries of all four group animals. ChIP assays were performed using the ChIP-IT kit (Active Motif, Carlsbad, CA), as previously described. 3, 4 Briefly, tissues were exposed to 1% formaldehyde for 10 minutes to crosslink and maintain DNA/protein interactions. After the reactions were stopped with glycine, tissues were washed, chromatin isolated and DNA sheared into medium fragments (100 -1000 bp) using a sonicator. ChIP reactions were performed using Sp1, USF1 or USF2 antibodies to precipitate the transcription factor/DNA complex. Crosslinking was then reversed using a salt solution and proteins digested with proteinase K. Primers flanking USF -15 and Sp1 -520 binding sites are shown in Table S2 (available in the online data supplement). PCR amplification products were visualized on 2% agarose gel stained with ethidium bromide. To quantify PCR amplification, 45 cycles of real-time PCR were carried out with 3 minutes initial denaturation followed by 95°C for 30 seconds, 59°C for 30 seconds, and 72°C for 30 seconds, using the iQ SYBR Green Supermix with iCycler real-time PCR system (Bio-Rad, Hercules, CA).
Site-Directed CpG Methylation Mutagenesis and Reporter Gene Assay.
The effect of site-directed CpG methylation on ER promoter activity was determined as described previously. 3 Briefly, to determine the effect of methylation at Sp1 -520 on ER promoter activity, a unique SacII cutting site was engineered at 3′ downstream of the Sp1 site. A customized 90-bp PflMI/SacII oligonucleotide fragment with methylation of CpG -516 at the Sp1 site was synthesized by IDT, and was then ligated back to the ER promoter-reporter plasmid with pGL3. An identical 90-bp PflMI/SacII fragment with unmethylated CpG -516 at the Sp1 site was served as a control. To determine the effect of methylation at USF -15 on ER promoter activity, two unique cutting sites of SacII and EcoRI were engineered at 3′ downstream and 5' upstream, respectively, of the USF site. A customized 30-bp EcoRI/SacII oligonucleotide fragment with methylation of CpG -13 at the USF site was synthesized by IDT, and was then ligated back to the ER promoter-reporter plasmid with pGL3. Amount of formed ligation product was quantified by real-time PCR and equal amount of plasmid was used in a transfection assay. Activities of each promoter-reporter constructs were determined in smooth muscle cells of uterine arteries from control nonpregnant sheep, as described above. Table S3 (available in the online data supplement) lists the oligonucleotide probes used in site-directed CpG methylation mutagenesis and reporter gene assay.
Data Analysis. Results are expressed as means ± SEM obtained from the number of experimental animals given. Differences were evaluated for statistical significance (P<0.05) by ANOVA or t test, where appropriate.
Table S2. Primers used in ChIP assay

Sp1 -520
Forward:
5'-gttcagaggcagggggatg-3' Reverse:
5'-tataatttaacaataaaag-3'
USF -15
Forward: 5'-catcccacatgcaaacacat-3' Reverse:
5'-gaagtcaagggctgagaca-3 '  Table S3 . Oligonucleotide probes used in site-directed CpG methylation mutagenesis and reporter gene assay 7   GCACAGGAGTGTCGGGGGAAGGGATAAATGGCAAAGCTAGAATGCTTA  GGCGTGCCAAAGGCTACAGAAAGCCTATAGGAGTGCCCTGGGTGACT  GCAGGATAATGATGCTAGTCACAGACTGGGGGGTTGGAGAGGAGCCC  CATGTCTGGGGGAAGGGAGAATGATGACTCATTTTCAATGAGCAGGCA  ATGCCCAAGAGACTGTTGGCAAAGTGGTCTGGAGATGCTCTCGATGGG  GAGCTACAGAAATAGACTTGACCCTAATTCCCCAGCAAATGCCAGGAA  GTCAAGGAGGGGAGTGTGAGCCCGTGCAGCTGGAGAGGGTAGAGGAG  GGAACCAGGCTGTAAAGTTGTTTGCCAGAAGCACTAGAAGAAAACTGG  CAAGGTTCGCTGTCCTTTCCCACCCACCATCATCAAGCCTGGGTGATG  ATTCTTACCAGGAATAGGAAGAGAATATGGGCAAGAGAGTGTTCTGGAA  AACTGACTGTATCGGACATCTGGGACTAACTTTGATGGTTAGTTATAGA  ATAATCAAAGTCTGTGAAGAGATAATGAGACTTCTTATCCTTCCTGTGTT  CAAGTAGAACAGTTGCAAAGTTCCTTTCCTCCCTCTTTCCCTCCTTTCTT  CCTTCCCTTTTTTCCTCTCCTTCCTCCCCCTTCTTTCCCTTTCCTCTCCA  TTCTTTGCACATTCTTGTTTTATTGGGGACTGGCCTAGTACATGCATGG  CCACGGTTGACCTAAAGGAGGAGTTAATACTCACAGCCATCAACAACAA  AGGGTTCTGTGCTCTAATACTGCAATATTTTGGGGACTTTCAAAGCACA  AAATACTATTTGCATTATGACATTATTAACATTTTGGTAACTTTTTTAAAA  ATAACTTTTTTACTTCTTTCTTTGTACTGGTCTTAAGAACCACTCATAAAT  CTCTCACTAACTGCATGAGGTACCAGGGCGAGAGACTGGCCACTCCTG  GCATTGTGATTAGAACCATTTAATACCCAAAGCAGTGACTAATGTCTGG  CAACAAAGGCTCCAGTAGGTGTCACATGTCCTTAGACATTGGTTAAGGG  CCACTAGGATCACTTTCTTTGTATGTTGGTACCATGGTCAAGAGAAACA  TTGAGAACCTGGAGGCTCTATGTGGGCATCATTGGGAAACAGGTCCTC  TACCCATGGTCAATGCCTCTACAACCAGAAAGCCTAAAATCAGTGCCAA  ACAAAGGCACCTACCTTTGTCTTATCTTCCTACTCTGGGATTTTAATGAT  ATATTTTTTTTCATGTTTACTGAAAGCAGTCAACTGAGCTATTCGTGGAA  AGGTTTGTGGGTTTGGTTAACGAGGTGGAGGAATATTACATTTCAGTTG  GAAACACCTCCCTAGAATGCCAAAACATTTATTCCAAAGTCTGGTTTCC  CGGTGCAATGGGAGGCACGGCAACAGTGTGTCTGTTCAGAGGCAGGG  GGATGGTGAGGAGGGACAGGGCGGGCTGGGGCCAGCAAGGCATCGG  AGGCATCGGATCCAAGTGGATCCCAGAAGGCTTTTATTGTTAAATTATA  TTCTTCAGGAAAAACCGCCTGTGTCACATTTTGTAAACTTGATATCCAC  GCACTTTTGACTGGCATTCTATTTTAGCCATAAGCCCATGACTTCCAGC  AAGCCTGCTTTCCCTCTTGCCTCGGATGGCAGCAGACAACATGGCACA  CTTTCTAGGCTCCAGGGAGAAGGAGCAGAAAGGCTTGGGAGTGTTGGT  TCCATCCAATAACGCTGACTTGAGTGTGCCACCCCGCTCCCTGTGAGC  AGACAGCAAGCCTCTCCTCACTCTCCACTGCCATTCATCCAGCTCTGTG  CGGCAGCCCAGCTGCTCTGTCTGCCGGGAGGGGCTGCCAAGTGCCCT  GCCTACTGGCTGCTTCCCGATTCCCTGCCATCCCACATGCAAACACAT  CCCCACACGCTCTGCCTTGCTCACACCCGGAGCCACAGGCACACGGG Following the transcription initiation site (+1), translation starts at +254 nucleotides for human, +153 nucleotides for bovine, and +149 nucleotides for ovine sequence.
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